190 related articles for article (PubMed ID: 36272554)
1. Impaired Ca
Bamgboye MA; Traficante MK; Owoyemi J; DiSilvestre D; Vieira DCO; Dick IE
J Mol Cell Cardiol; 2022 Dec; 173():92-100. PubMed ID: 36272554
[TBL] [Abstract][Full Text] [Related]
2. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
[TBL] [Abstract][Full Text] [Related]
3. Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8).
Drum BM; Dixon RE; Yuan C; Cheng EP; Santana LF
J Mol Cell Cardiol; 2014 Jan; 66():63-71. PubMed ID: 24215710
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.
Wemhöner K; Friedrich C; Stallmeyer B; Coffey AJ; Grace A; Zumhagen S; Seebohm G; Ortiz-Bonnin B; Rinné S; Sachse FB; Schulze-Bahr E; Decher N
J Mol Cell Cardiol; 2015 Mar; 80():186-95. PubMed ID: 25633834
[TBL] [Abstract][Full Text] [Related]
5. Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein.
Cheng EP; Yuan C; Navedo MF; Dixon RE; Nieves-Cintrón M; Scott JD; Santana LF
Circ Res; 2011 Jul; 109(3):255-61. PubMed ID: 21700933
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
[TBL] [Abstract][Full Text] [Related]
7. Increased coupled gating of L-type Ca2+ channels during hypertension and Timothy syndrome.
Navedo MF; Cheng EP; Yuan C; Votaw S; Molkentin JD; Scott JD; Santana LF
Circ Res; 2010 Mar; 106(4):748-56. PubMed ID: 20110531
[TBL] [Abstract][Full Text] [Related]
8. Disrupted Ca
Kashiwa A; Makiyama T; Kohjitani H; Maurissen TL; Ishikawa T; Yamamoto Y; Wuriyanghai Y; Gao J; Huang H; Imamura T; Aizawa T; Nishikawa M; Chonabayashi K; Mishima H; Ohno S; Toyoda F; Sato S; Yoshiura KI; Takahashi K; Yoshida Y; Woltjen K; Horie M; Makita N; Kimura T
Heart Rhythm; 2023 Jan; 20(1):89-99. PubMed ID: 36007726
[TBL] [Abstract][Full Text] [Related]
9. The LQT-associated calmodulin mutant E141G induces disturbed Ca
Su J; Gao Q; Yu L; Sun X; Feng R; Shao D; Yuan Y; Zhu Z; Sun X; Kameyama M; Hao L
Am J Physiol Cell Physiol; 2020 May; 318(5):C991-C1004. PubMed ID: 32186935
[TBL] [Abstract][Full Text] [Related]
10. Exclusion of alternative exon 33 of Ca
Li G; Wang J; Liao P; Bartels P; Zhang H; Yu D; Liang MC; Poh KK; Yu CY; Jiang F; Yong TF; Wong YP; Hu Z; Huang H; Zhang G; Galupo MJ; Bian JS; Ponniah S; Trasti SL; See K; Foo R; Hoppe UC; Herzig S; Soong TW
Proc Natl Acad Sci U S A; 2017 May; 114(21):E4288-E4295. PubMed ID: 28490495
[TBL] [Abstract][Full Text] [Related]
11. Calmodulin variant E140G associated with long QT syndrome impairs CaMKIIδ autophosphorylation and L-type calcium channel inactivation.
Prakash O; Gupta N; Milburn A; McCormick L; Deugi V; Fisch P; Wyles J; Thomas NL; Antonyuk S; Dart C; Helassa N
J Biol Chem; 2023 Jan; 299(1):102777. PubMed ID: 36496072
[TBL] [Abstract][Full Text] [Related]
12. A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis.
Hennessey JA; Boczek NJ; Jiang YH; Miller JD; Patrick W; Pfeiffer R; Sutphin BS; Tester DJ; Barajas-Martinez H; Ackerman MJ; Antzelevitch C; Kanter R; Pitt GS
PLoS One; 2014; 9(9):e106982. PubMed ID: 25184293
[TBL] [Abstract][Full Text] [Related]
13. Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish Family.
Nieto-Marín P; Jiménez-Jáimez J; Tinaquero D; Alfayate S; Utrilla RG; Rodríguez Vázquez Del Rey MDM; Perin F; Sarquella-Brugada G; Monserrat L; Brugada J; Tercedor L; Tamargo J; Delpón E; Caballero R
Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):324-332. PubMed ID: 29691127
[TBL] [Abstract][Full Text] [Related]
14. State-dependent signaling by Cav1.2 regulates hair follicle stem cell function.
Yucel G; Altindag B; Gomez-Ospina N; Rana A; Panagiotakos G; Lara MF; Dolmetsch R; Oro AE
Genes Dev; 2013 Jun; 27(11):1217-22. PubMed ID: 23752588
[TBL] [Abstract][Full Text] [Related]
15. Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.
Limpitikul WB; Dick IE; Joshi-Mukherjee R; Overgaard MT; George AL; Yue DT
J Mol Cell Cardiol; 2014 Sep; 74():115-24. PubMed ID: 24816216
[TBL] [Abstract][Full Text] [Related]
16. Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes.
Pipilas DC; Johnson CN; Webster G; Schlaepfer J; Fellmann F; Sekarski N; Wren LM; Ogorodnik KV; Chazin DM; Chazin WJ; Crotti L; Bhuiyan ZA; George AL
Heart Rhythm; 2016 Oct; 13(10):2012-9. PubMed ID: 27374306
[TBL] [Abstract][Full Text] [Related]
17. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.
Yazawa M; Hsueh B; Jia X; Pasca AM; Bernstein JA; Hallmayer J; Dolmetsch RE
Nature; 2011 Mar; 471(7337):230-4. PubMed ID: 21307850
[TBL] [Abstract][Full Text] [Related]
18. Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation.
Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
Toxicol Sci; 2019 Feb; 167(2):573-580. PubMed ID: 30365015
[TBL] [Abstract][Full Text] [Related]
19. The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation.
Yarotskyy V; Gao G; Peterson BZ; Elmslie KS
J Physiol; 2009 Feb; 587(3):551-65. PubMed ID: 19074970
[TBL] [Abstract][Full Text] [Related]
20. KCNE2 modulates cardiac L-type Ca(2+) channel.
Liu W; Deng J; Wang G; Zhang C; Luo X; Yan D; Su Q; Liu J
J Mol Cell Cardiol; 2014 Jul; 72():208-18. PubMed ID: 24681347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
